Dengue virus life cycle: Viral and host factors modulating infectivity

Cellular and Molecular Life Sciences

Volumn 67, Issue 16, 2010, Pages 2773-2786

  Rodenhuis Zybert, Izabela A ^a   Wilschut, Jan ^a   Smit, Jolanda M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antibody dependent enhancement; Dengue; Flavivirus; Host factors; Immune response; Life cycle; Pathogenesis; Virulence

Indexed keywords

NONSTRUCTURAL PROTEIN 1; UNCLASSIFIED DRUG; VIRUS E PROTEIN; VIRUS PROTEIN;

ANTIBODY RESPONSE; CELLULAR IMMUNITY; CYTOKINE STORM; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; GENOTYPE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN GLYCOSYLATION; REVIEW; STRUCTURE ANALYSIS; T LYMPHOCYTE; VIRION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANTIBODY FORMATION; DENDRITIC CELLS; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DIMERIZATION; FLAVIVIRUS; GLYCOSYLATION; HUMANS; LIFE CYCLE STAGES; MACROPHAGES; MODELS, MOLECULAR; MONOCYTES; NEUTRALIZATION TESTS; SEROTYPING; SKIN; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

ARTHROPODA; DENGUE VIRUS; FLAVIVIRUS;

EID: 77955710423     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0357-z     Document Type: Review

References (209)

1. DJ Gubler 2006 Dengue/dengue haemorrhagic fever: history and current status Novartis Found Symp 277 3 16 17319151
2. World Health Organization. WHO report on global surveillance of epidemic-prone infectious diseases-dengue and dengue haemorrhagic fever. World Health Organization. http://www.who.int/csr/resources/publications/dengue/CSR- ISR-2000-1/en/. Accessed 9 March 2010
3. Burke DS, Monath TP (2001) Flaviviruses. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams and Wilkins, Philadelphia, pp 1043-1125
4. SB Halstead 1970 Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion Yale J Biol Med 42 350 362 5419208
5. DS Burke A Nisalak DE Johnson RM Scott 1988 A prospective study of dengue infections in Bangkok Am J Trop Med Hyg 38 172 180 3341519
6. MG Guzman G Kouri L Valdes J Bravo S Vazquez SB Halstead 2002 Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks Rev Panam Salud Publica 11 223 227 12049030
7. M Recker KB Blyuss CP Simmons TT Hien B Wills J Farrar S Gupta 2009 Immunological serotype interactions and their effect on the epidemiological pattern of dengue Proc Biol Sci 276 2541 2548 19369266
8. S Thein MM Aung TN Shwe M Aye A Zaw K Aye KM Aye J Aaskov 1997 Risk factors in dengue shock syndrome Am J Trop Med Hyg 56 566 572 9180609
9. SB Halstead NT Lan TT Myint TN Shwe A Nisalak S Kalyanarooj S Nimmannitya S Soegijanto DW Vaughn TP Endy 2002 Dengue hemorrhagic fever in infants: research opportunities ignored Emerg Infect Dis 8 1474 1479 12498666
10. SC Kliks S Nimmanitya A Nisalak DS Burke 1988 Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants Am J Trop Med Hyg 38 411 419 3354774
11. DJ Gubler 2002 Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century Trends Microbiol 10 100 103 11827812
12. MG Guzman G Kouri J Bravo L Valdes S Vazquez SB Halstead 2002 Effect of age on outcome of secondary dengue 2 infections Int J Infect Dis 6 118 124 12121599
13. B Sierra R Alegre AB Perez G Garcia K Sturn-Ramirez O Obasanjo E Aguirre M Alvarez R Rodriguez-Roche L Valdes P Kanki MG Guzman 2007 HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection Hum Immunol 68 531 540 17509453
14. U Thisyakorn S Nimmannitya 1993 Nutritional status of children with dengue hemorrhagic fever Clin Infect Dis 16 295 297 8443312
15. SJ Thomas D Strickman DW Vaughn 2003 Dengue epidemiology: virus epidemiology, ecology, and emergence Adv Virus Res 61 235 289 14714434
16. E Harris KL Holden D Edgil C Polacek K Clyde 2006 Molecular biology of flaviviruses Novartis Found Symp 277 23 39 17319152
17. BD Lindenbach CM Rice 2003 Molecular biology of flaviviruses Adv Virus Res 59 23 61 14696326
18. L Ma CT Jones TD Groesch RJ Kuhn CB Post 2004 Solution structure of dengue virus capsid protein reveals another fold Proc Natl Acad Sci USA 101 3414 3419 14993605
19. CT Jones L Ma JW Burgner TD Groesch CB Post RJ Kuhn 2003 Flavivirus capsid is a dimeric alpha-helical protein J Virol 77 7143 7149 12768036
20. CJ Chang HW Luh SH Wang HJ Lin SC Lee ST Hu 2001 The heterogeneous nuclear ribonucleoprotein K (hnRNP K) interacts with dengue virus core protein DNA Cell Biol 20 569 577 11747608
21. FA Rey FX Heinz C Mandl C Kunz SC Harrison 1995 The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution Nature 375 291 298 7753193
22. GE Nybakken CA Nelson BR Chen MS Diamond DH Fremont 2006 Crystal structure of the West Nile virus envelope glycoprotein J Virol 80 11467 11474 16987985
23. Y Modis S Ogata D Clements SC Harrison 2003 A ligand-binding pocket in the dengue virus envelope glycoprotein Proc Natl Acad Sci USA 100 6986 6991 12759475
24. Y Modis S Ogata D Clements SC Harrison 2005 Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein J Virol 79 1223 1231 15613349
25. RJ Kuhn W Zhang MG Rossmann SV Pletnev J Corver E Lenches CT Jones S Mukhopadhyay PR Chipman EG Strauss TS Baker JH Strauss 2002 Structure of dengue virus: implications for flavivirus organization, maturation, and fusion Cell 108 717 725 11893341
26. Y Zhang W Zhang S Ogata D Clements JH Strauss TS Baker RJ Kuhn MG Rossmann 2004 Conformational changes of the flavivirus E glycoprotein Structure 12 1607 1618 15341726
27. S Mukhopadhyay RJ Kuhn MG Rossmann 2005 A structural perspective of the flavivirus life cycle Nat Rev Microbiol 3 13 22 15608696
28. K Clyde JL Kyle E Harris 2006 Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis J Virol 80 11418 11431 16928749
29. JE Bryant AE Calvert K Mesesan MB Crabtree KE Volpe S Silengo RM Kinney CY Huang BR Miller JT Roehrig 2007 Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes Virology 366 415 423 17543367
30. MB Crabtree RM Kinney BR Miller 2005 Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses Arch Virol 150 771 786 15592895
31. M Flamand F Megret M Mathieu J Lepault FA Rey V Deubel 1999 Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion J Virol 73 6104 6110 10364366
32. Y Zhang J Corver PR Chipman W Zhang SV Pletnev D Sedlak TS Baker JH Strauss RJ Kuhn MG Rossmann 2003 Structures of immature flavivirus particles EMBO J 22 2604 2613 12773377
33. W Zhang PR Chipman J Corver PR Johnson Y Zhang S Mukhopadhyay TS Baker JH Strauss MG Rossmann RJ Kuhn 2003 Visualization of membrane protein domains by cryo-electron microscopy of dengue virus Nat Struct Biol 10 907 912 14528291
34. SL Allison K Stadler CW Mandl C Kunz FX Heinz 1995 Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form J Virol 69 5816 5820 7637027
35. BA Fonseca S Pincus RE Shope E Paoletti PW Mason 1994 Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice Vaccine 12 279 285 8165861
36. AR Hunt CB Cropp GJ Chang 2001 A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen J Virol Methods 97 133 149 11483224
37. E Konishi A Fujii 2002 Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine Vaccine 20 1058 1067 11803066
38. Y Zhang B Kaufmann PR Chipman RJ Kuhn MG Rossmann 2007 Structure of immature West Nile virus J Virol 81 6141 6145 17376919
39. Zybert IA, van dE-M, Wilschut J, Smit JM (2008) Functional importance of dengue virus maturation: infectious properties of immature virions. J Gen Virol 89:3047-3051
40. IM Yu W Zhang HA Holdaway L Li VA Kostyuchenko PR Chipman RJ Kuhn MG Rossmann J Chen 2008 Structure of the immature dengue virus at low pH primes proteolytic maturation Science 319 1834 1837 18369148
41. K Stadler SL Allison J Schalich FX Heinz 1997 Proteolytic activation of tick-borne encephalitis virus by furin J Virol 71 8475 8481 9343204
42. K Jessie MY Fong S Devi SK Lam KT Wong 2004 Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization J Infect Dis 189 1411 1418 15073678
43. SJ Wu G Grouard-Vogel W Sun JR Mascola E Brachtel R Putvatana MK Louder L Filgueira MA Marovich HK Wong A Blauvelt GS Murphy ML Robb BL Innes DL Birx CG Hayes SS Frankel 2000 Human skin Langerhans cells are targets of dengue virus infection Nat Med 6 816 820 10888933
44. RF Mercado-Curiel WC Black ML Munoz 2008 A dengue receptor as possible genetic marker of vector competence in Aedes aegypti BMC Microbiol 8 118 18625079
45. A Molina-Cruz L Gupta J Richardson K Bennett W Black C Barillas-Mury 2005 Effect of mosquito midgut trypsin activity on dengue-2 virus infection and dissemination in Aedes aegypti Am J Trop Med Hyg 72 631 637 15891140
46. MI Salazar JH Richardson I Sanchez-Vargas KE Olson BJ Beaty 2007 Dengue virus type 2: replication and tropisms in orally infected Aedes aegypti mosquitoes BMC Microbiol 7 9 17263893
47. S Sriurairatna N Bhamarapravati 1977 Replication of dengue-2 virus in Aedes albopictus mosquitoes. An electron microscopic study Am J Trop Med Hyg 26 1199 1205 596516
48. van der Schaar HM, Rust MJ, Waarts BL, van dE-M, Kuhn RJ, Wilschut J, Zhuang X, Smit JM (2007) Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81:12019-12028
49. P Avirutnan P Malasit B Seliger S Bhakdi M Husmann 1998 Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis J Immunol 161 6338 6346 9834124
50. A Cabrera-Hernandez C Thepparit L Suksanpaisan DR Smith 2007 Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70 J Med Virol 79 386 392 17311328
51. T Chareonsirisuthigul S Kalayanarooj S Ubol 2007 Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells J Gen Virol 88 365 375 17251552
52. ST Chen YL Lin MT Huang MF Wu SC Cheng HY Lei CK Lee TW Chiou CH Wong SL Hsieh 2008 CLEC5A is critical for dengue-virus-induced lethal disease Nature 453 672 676 18496526
53. D Edgil MS Diamond KL Holden SM Paranjape E Harris 2003 Translation efficiency determines differences in cellular infection among dengue virus type 2 strains Virology 317 275 290 14698666
54. GD Gromowski AD Barrett 2007 Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus Virology 366 349 360 17719070
55. SB Halstead 2003 Neutralization and antibody-dependent enhancement of dengue viruses Adv Virus Res 60 421 467 14689700
56. KJ Huang YC Yang YS Lin JH Huang HS Liu TM Yeh SH Chen CC Liu HY Lei 2006 The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection J Immunol 176 2825 2832 16493039
57. CA King JS Marshall H Alshurafa R Anderson 2000 Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line J Virol 74 7146 7150 10888655
58. I Kurane A Meager FA Ennis 1989 Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity J Exp Med 170 763 775 2475573
59. YL Lin CC Liu JI Chuang HY Lei TM Yeh YS Lin YH Huang HS Liu 2000 Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells Virology 276 114 126 11022000
60. R Littaua I Kurane FA Ennis 1990 Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection J Immunol 144 3183 3186 2139079
61. MM Moreno-Altamirano FJ Sanchez-Garcia M Legorreta-Herrera I guilar-Carmona 2007 Susceptibility of mouse macrophage J774 to dengue virus infection Intervirology 50 237 239 17356302
62. VJ Reyes-Del S Chavez-Salinas F Medina RM Del Angel 2005 Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells J Virol 79 4557 4567
63. RF Mercado-Curiel HA Esquinca-Aviles R Tovar A az-Badillo M Camacho-Nuez ML Munoz 2006 The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells BMC Microbiol 6 85 17014723
64. MM Yazi JS Salas-Benito H Lanz-Mendoza S Hernandez-Martinez RM Del Angel 2002 A putative receptor for dengue virus in mosquito tissues: localization of a 45-kDa glycoprotein Am J Trop Med Hyg 67 76 84
65. Y Chen T Maguire RE Hileman JR Fromm JD Esko RJ Linhardt RM Marks 1997 Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Nat Med 3 866 871 9256277
66. R Germi JM Crance D Garin J Guimet H Lortat-Jacob RW Ruigrok JP Zarski E Drouet 2002 Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus Virology 292 162 168 11878919
67. P Hilgard R Stockert 2000 Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes Hepatology 32 1069 1077 11050058
68. YC Chen SY Wang CC King 1999 Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism J Virol 73 2650 2657 10074110
69. S Jindadamrongwech C Thepparit DR Smith 2004 Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2 Arch Virol 149 915 927 15098107
70. C Thepparit DR Smith 2004 Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor J Virol 78 12647 12656 15507651
71. MD Fernandez-Garcia M Mazzon M Jacobs A Amara 2009 Pathogenesis of flavivirus infections: using and abusing the host cell Cell Host. Microbe 5 318 328 19380111
72. PY Lozach L Burleigh I Staropoli E Navarro-Sanchez J Harriague JL Virelizier FA Rey P Despres F Renzana-Seisdedos A Amara 2005 Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals J Biol Chem 280 23698 23708 15855154
73. E Navarro-Sanchez R Altmeyer A Amara O Schwartz F Fieschi JL Virelizier F renzana-Seisdedos P Despres 2003 Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses EMBO Rep 4 723 728 12783086
74. B Tassaneetrithep TH Burgess A Granelli-Piperno C Trumpfheller J Finke W Sun MA Eller K Pattanapanyasat S Sarasombath DL Birx RM Steinman S Schlesinger MA Marovich 2003 DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells J Exp Med 197 823 829 12682107
75. JL Miller BJ de Wet L Martinez-Pomares CM Radcliffe RA Dwek PM Rudd S Gordon 2008 The mannose receptor mediates dengue virus infection of macrophages PLoS Pathog 4 e17 18266465
76. EG Acosta V Castilla EB Damonte 2008 Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis J Gen Virol 89 474 484 18198378
77. van der Schaar HM, Rust MJ, Chen C, van dE-M, Wilschut J, Zhuang X, Smit JM (2008) Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4:e1000244
78. MN Krishnan B Sukumaran U Pal H Agaisse JL Murray TW Hodge E Fikrig 2007 Rab 5 is required for the cellular entry of dengue and West Nile viruses J Virol 81 4881 4885 17301152
79. JJ Chu ML Ng 2004 Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway J Virol 78 10543 10555 15367621
80. M Nawa 1984 Development of a new cell system for the infectivity assay of dengue viruses: plaque formation and virus growth of prototype and wild-type dengue virus strains in a newly established cell line, GK Microbiol Immunol 28 765 776 6493074
81. EG Acosta V Castilla EB Damonte 2009 Alternative infectious entry pathways for dengue virus serotypes into mammalian cells Cell Microbiol 11 1533 1549 19523154
82. SC Harrison 2008 Viral membrane fusion Nat Struct Mol Biol 15 690 698 18596815
83. FX Heinz SL Allison 2003 Flavivirus structure and membrane fusion Adv Virus Res 59 63 97 14696327
84. M Kielian FA Rey 2006 Virus membrane-fusion proteins: more than one way to make a hairpin Nat Rev Microbiol 4 67 76 16357862
85. Y Modis S Ogata D Clements SC Harrison 2004 Structure of the dengue virus envelope protein after membrane fusion Nature 427 313 319 14737159
86. K Stiasny SL Allison J Schalich FX Heinz 2002 Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH J Virol 76 3784 3790 11907218
87. MS Diamond TG Roberts D Edgil B Lu J Ernst E Harris 2000 Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons J Virol 74 4957 4966 10799569
88. LJ Ho LF Hung CY Weng WL Wu P Chou YL Lin DM Chang TY Tai JH Lai 2005 Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell J Immunol 174 8163 8172 15944325
89. AJ Johnson JT Roehrig 1999 New mouse model for dengue virus vaccine testing J Virol 73 783 786 9847388
90. S Shresta JL Kyle HM Snider M Basavapatna PR Beatty E Harris 2004 Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical J Virol 78 2701 2710 14990690
91. EL Azeredo LM De Oliveira-Pinto SM Zagne DI Cerqueira RM Nogueira CF Kubelka 2006 NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease Clin Exp Immunol 143 345 356 16412060
92. S Shresta JL Kyle BP Robert E Harris 2004 Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice Virology 319 262 273 14980486
93. S Akira 2006 TLR signaling Curr Top Microbiol Immunol 311 1 16 17048703
94. G Trinchieri A Sher 2007 Cooperation of Toll-like receptor signals in innate immune defence Nat Rev Immunol 7 179 190 17318230
95. de K, Setiati TE, Mairuhu AT, Koraka P, Aberson HA, Spek CA, Osterhaus AD, Reitsma PH, Brandjes DP, Soemantri A, van Gorp EC (2008) Differential gene expression changes in children with severe dengue virus infections. PLoS Negl Trop Dis 2:e215
96. YT Tsai SY Chang CN Lee CL Kao 2009 Human TLR3 recognizes dengue virus and modulates viral replication in vitro Cell Microbiol 11 604 615 19134117
97. M Aebi J Fah N Hurt CE Samuel D Thomis L Bazzigher J Pavlovic O Haller P Staeheli 1989 cDNA structures and regulation of two interferon-induced human Mx proteins Mol Cell Biol 9 5062 5072 2481229
98. MJ Clemens BR Williams 1978 Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: a novel oligonucleotide synthesized by interferon-treated L cell extracts Cell 13 565 572 657268
99. J Pavlovic T Zurcher O Haller P Staeheli 1990 Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein J Virol 64 3370 3375 2161946
100. CE Samuel 1981 Molecular mechanisms of interferon action: interferon-mediated phosphorylation of ribosome-associated protein P1 and protein synthesis initiation factor eIF-2 Tex. Rep. Biol. Med. 41 463 470 6189210
101. I Kurane FA Ennis 1988 Production of interferon alpha by dengue virus-infected human monocytes J Gen Virol 69 Pt 2 445 449 3339332
102. S Shresta KL Sharar DM Prigozhin HM Snider PR Beatty E Harris 2005 Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice J Immunol 175 3946 3954 16148142
103. AK Erickson M Gale Jr 2008 Regulation of interferon production and innate antiviral immunity through translational control of IRF-7 Cell Res 18 433 435 18385680
104. J Ashour M Laurent-Rolle PY Shi A Garcia-Sastre 2009 NS5 of dengue virus mediates STAT2 binding and degradation J Virol 83 5408 5418 19279106
105. M Jones A Davidson L Hibbert P Gruenwald J Schlaak S Ball GR Foster M Jacobs 2005 Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression J Virol 79 5414 5420 15827155
106. JL Munoz-Jordan GG Sanchez-Burgos M Laurent-Rolle A Garcia-Sastre 2003 Inhibition of interferon signaling by dengue virus Proc Natl Acad Sci USA 100 14333 14338 14612562
107. I Umareddy KF Tang SG Vasudevan S Devi ML Hibberd F Gu 2008 Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines J Gen Virol 89 3052 3062 19008393
108. R Takhampunya DR Palmer S McClain DA Barvir J Lynch RG Jarman S Thomas RV Gibbons TH Burgess P Sun E Kamau R Putnak C Zhang 2009 Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling ability Virus Res 145 31 38 19540887
109. MJ Cardosa SM Wang MS Sum PH Tio 2002 Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses BMC Microbiol 2 9 12019028
110. CY Lai WY Tsai SR Lin CL Kao HP Hu CC King HC Wu GJ Chang WK Wang 2008 Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II J Virol 82 6631 6643 18448542
111. PY Shu LK Chen SF Chang YY Yueh L Chow LJ Chien C Chin TH Lin JH Huang 2000 Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever J Med Virol 62 224 232 11002252
112. DH Libraty PR Young D Pickering TP Endy S Kalayanarooj S Green DW Vaughn A Nisalak FA Ennis AL Rothman 2002 High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever J Infect Dis 186 1165 1168 12355369
113. SM Costa MS Freire AM Alves 2006 DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus Vaccine 24 4562 4564 16140430
114. EA Henchal LS Henchal JJ Schlesinger 1988 Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus J Gen Virol 69 Pt 8 2101 2107 3404125
115. T Kurosu P Chaichana M Yamate S Anantapreecha K Ikuta 2007 Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1 Biochem Biophys Res Commun 362 1051 1056 17825259
116. JJ Schlesinger MW Brandriss EE Walsh 1987 Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1 J Gen Virol 68 Pt 3 853 857 3819700
117. BM Kaufman PL Summers DR Dubois KH Eckels 1987 Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection Am J Trop Med Hyg 36 427 434 3826503
118. BM Kaufman PL Summers DR Dubois WH Cohen MK Gentry RL Timchak DS Burke KH Eckels 1989 Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection Am J Trop Med Hyg 41 576 580 2817214
119. IA Rodenhuis-Zybert HM van der Schaar JM da Silva Voorham H van der Ende-Metselaar HY Lei J Wilschut JM Smit 2010 Immature dengue virus: a veiled pathogen? PLoS Pathog 6 e1000718 20062797
120. TC Pierson Q Xu S Nelson T Oliphant GE Nybakken DH Fremont MS Diamond 2007 The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection Cell Host Microbe 1 135 145 18005691
121. O Lisova F Hardy V Petit H Bedouelle 2007 Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus J Gen Virol 88 2387 2397 17698647
122. T Oliphant GE Nybakken M Engle Q Xu CA Nelson S Sukupolvi-Petty A Marri BE Lachmi U Olshevsky DH Fremont TC Pierson MS Diamond 2006 Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein J Virol 80 12149 12159 17035317
123. R Rajamanonmani C Nkenfou P Clancy YH Yau SG Shochat S Sukupolvi-Petty W Schul MS Diamond SG Vasudevan J Lescar 2009 On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes J Gen Virol 90 799 809 19264660
124. S Nelson CA Jost Q Xu J Ess JE Martin T Oliphant SS Whitehead AP Durbin BS Graham MS Diamond TC Pierson 2008 Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization PLoS Pathog 4 e1000060 18464894
125. GE Nybakken T Oliphant S Johnson S Burke MS Diamond DH Fremont 2005 Structural basis of West Nile virus neutralization by a therapeutic antibody Nature 437 764 769 16193056
126. BS Thompson B Moesker JM Smit J Wilschut MS Diamond DH Fremont 2009 A therapeutic antibody against west Nile virus neutralizes infection by blocking fusion within endosomes PLoS Pathog 5 e1000453 19478866
127. van der Schaar HM, Wilschut JC, Smit JM (2009) Role of antibodies in controlling dengue virus infection. Immunobiology. doi: 10.1016/j.imbio.2008.11. 008
128. SB Halstead EJ O'Rourke 1977 Antibody-enhanced dengue virus infection in primate leukocytes Nature 265 739 741 404559
129. SB Halstead EJ O'Rourke 1977 Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody J Exp Med 146 201 217 406347
130. VB Randolph G Winkler V Stollar 1990 Acidotropic amines inhibit proteolytic processing of flavivirus prM protein Virology 174 450 458 2154882
131. KJ Huang YC Yang YS lin HS liu TM Yeh SH Chen CC Liu HY Lei 2005 Flow cytometric determination for dengue virus-infected cells: its application for antibody-dependent enhancement study Dengue Bull 29 142 150
132. J Mongkolsapaya W Dejnirattisai XN Xu S Vasanawathana N Tangthawornchaikul A Chairunsri S Sawasdivorn T Duangchinda T Dong S Rowland-Jones PT Yenchitsomanus A McMichael P Malasit G Screaton 2003 Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever Nat Med 9 921 927 12808447
133. J Mongkolsapaya T Duangchinda W Dejnirattisai S Vasanawathana P Avirutnan A Jairungsri N Khemnu N Tangthawornchaikul P Chotiyarnwong K Sae-Jang M Koch Y Jones A McMichael X Xu P Malasit G Screaton 2006 T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol 176 3821 3829 16517753
134. AL Rothman 2009 T lymphocyte responses to heterologous secondary dengue virus infections Ann N Y Acad Sci 1171 suppl 1 E36 E41 19751400
135. AL Rothman 2010 Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis Curr Top Microbiol Immunol 338 83 98 19802580
136. G Screaton J Mongkolsapaya 2006 T cell responses and dengue haemorrhagic fever Novartis Found Symp 277 164 171 17319161
137. LE Yauch RM Zellweger MF Kotturi A Qutubuddin J Sidney B Peters TR Prestwood A Sette S Shresta 2009 A protective role for dengue virus-specific CD8+ T cells J Immunol 182 4865 4873 19342665
138. A Mathew AL Rothman 2008 Understanding the contribution of cellular immunity to dengue disease pathogenesis Immunol Rev 225 300 313 18837790
139. EL Azeredo SM Zagne MA Santiago AS Gouvea AA Santana PC Neves-Souza RM Nogueira MP Miagostovich CF Kubelka 2001 Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever Immunobiology 204 494 507 11776403
140. A Basu UC Chaturvedi 2008 Vascular endothelium: the battlefield of dengue viruses FEMS Immunol Med Microbiol 53 287 299 18522648
141. FA Bozza OG Cruz SM Zagne EL Azeredo RM Nogueira EF Assis PT Bozza CF Kubelka 2008 Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity BMC Infect Dis 8 86 18578883
142. A Chakravarti R Kumaria 2006 Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak Indian J Med Res 123 25 30 16567864
143. T Dong E Moran CN Vinh C Simmons K Luhn Y Peng B Wills DN Phuong TL Thi Thu TT Hien A McMichael J Farrar S Rowland-Jones 2007 High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection PLoS One 2 e1192 18060049
144. S Green DW Vaughn S Kalayanarooj S Nimmannitya S Suntayakorn A Nisalak AL Rothman FA Ennis 1999 Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity J Med Virol 59 329 334 10502265
145. D Hober L Poli B Roblin P Gestas E Chungue G Granic P Imbert JL Pecarere R Vergez-Pascal P Wattre 1993 Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients Am J Trop Med Hyg 48 324 331 8470771
146. I Kurane BL Innis S Nimmannitya A Nisalak A Meager J Janus FA Ennis 1991 Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue J Clin Invest 88 1473 1480 1939640
147. S Shresta KL Sharar DM Prigozhin PR Beatty E Harris 2006 Murine model for dengue virus-induced lethal disease with increased vascular permeability J Virol 80 10208 10217 17005698
148. C Suharti EC van Gorp WM Dolmans TE Setiati CE Hack R Djokomoeljanto JW van der Meer 2003 Cytokine patterns during dengue shock syndrome Eur Cytokine Netw 14 172 177 14656693
149. A Atrasheuskaya P Petzelbauer TM Fredeking G Ignatyev 2003 Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection FEMS Immunol Med Microbiol 35 33 42 12589955
150. P Aichele K Brduscha-Riem S Oehen B Odermatt RM Zinkernagel H Hengartner H Pircher 1997 Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology Immunity 6 519 529 9175830
151. MM Mangada AL Rothman 2005 Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes J Immunol 175 2676 2683 16081844
152. TH Nguyen HY Lei TL Nguyen YS Lin KJ Huang BL Le CF Lin TM Yeh QH Do TQ Vu LC Chen JH Huang TM Lam CC Liu SB Halstead 2004 Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles J Infect Dis 189 221 232 14722886
153. CP Simmons TN Chau TT Thuy NM Tuan DM Hoang NT Thien lB Lien NT Quy NT Hieu TT Hien C McElnea P Young S Whitehead NT Hung J Farrar 2007 Maternal antibody and viral factors in the pathogenesis of dengue virus in infants J Infect Dis 196 416 424 17597456
154. P Sun S Fernandez MA Marovich DR Palmer CM Celluzzi K Boonnak Z Liang H Subramanian KR Porter W Sun TH Burgess 2009 Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus Virology 383 207 215 19013627
155. K Boonnak BM Slike TH Burgess RM Mason SJ Wu P Sun K Porter IF Rudiman D Yuwono P Puthavathana MA Marovich 2008 Role of dendritic cells in antibody-dependent enhancement of dengue virus infection J Virol 82 3939 3951 18272578
156. S Weaver N Vasilakis 2009 Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arbovial disease Infect Genet Evol 9 523 540 19460319
157. J Blok AJ Gibbs SM McWilliam UT Vitarana 1991 NS 1 gene sequences from eight dengue-2 viruses and their evolutionary relationships with other dengue-2 viruses Arch Virol 118 209 223 1829885
158. N Kanakaratne WM Wahala WB Messer HA Tissera A Shahani N Abeysinghe AM de-Silva M Gunasekera 2009 Severe dengue epidemics in Sri Lanka, 2003-2006 Emerg Infect Dis 15 192 199 19193262
159. MN Mangada A Igarashi 1997 Sequences of terminal non-coding regions from four dengue-2 viruses isolated from patients exhibiting different disease severities Virus Genes 14 5 12 9208450
160. MN Mangada A Igarashi 1998 Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities Virology 244 458 466 9601513
161. WB Messer DJ Gubler E Harris K Sivananthan AM de Silva 2003 Emergence and global spread of a dengue serotype 3, subtype III virus Emerg Infect Dis 9 800 809 12899133
162. BD Pandey A Igarashi 2000 Severity-related molecular differences among nineteen strains of dengue type 2 viruses Microbiol Immunol 44 179 188 10789505
163. M Raekiansyah A Pramesyanti B Bela H Kosasih CN Ma'roef SY Tobing PI Rudiman B Alisjahbana TP Endi S Green S Kalayanarooj AL Rothman TM Sudiro 2005 Genetic variations and relationship among dengue virus type 3 strains isolated from patients with mild or severe form of dengue disease in Indonesia and Thailand Southeast Asian J Trop Med Public Health 36 1187 1197 16438144
164. R Rico-Hesse LM Harrison RA Salas D Tovar A Nisalak C Ramos J Boshell MT de Mesa RM Nogueira AT da Rosa 1997 Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas Virology 230 244 251 9143280
165. DM Watts KR Porter P Putvatana B Vasquez C Calampa CG Hayes SB Halstead 1999 Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever Lancet 354 1431 1434 10543670
166. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, de C, Ramos C, Rico-Hesse R (1999) Dengue virus structural differences that correlate with pathogenesis. J Virol 73:4738-4747
167. R Cologna PM Armstrong R Rico-Hesse 2005 Selection for virulent dengue viruses occurs in humans and mosquitoes J Virol 79 853 859 15613313
168. MJ Pryor JM Carr H Hocking AD Davidson P Li PJ Wright 2001 Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein Am J Trop Med Hyg 65 427 434 11716094
169. MJ Pryor PJ Wright 1994 Glycosylation mutants of dengue virus NS1 protein J Gen Virol 75 Pt 5 1183 1187 8176380
170. MJ Pryor RC Gualano B Lin AD Davidson PJ Wright 1998 Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins J Gen Virol 79 Pt 11 2631 2639 9820138
171. V Vorndam JH Mathews AD Barrett JT Roehrig DW Trent 1993 Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus J Gen Virol 74 Pt 12 2653 2660 7506301
172. E Pokidysheva Y Zhang AJ Battisti CM Bator-Kelly PR Chipman C Xiao GG Gregorio WA Hendrickson RJ Kuhn MG Rossmann 2006 Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN Cell 124 485 493 16469696
173. S Tajima T Takasaki I Kurane 2008 Characterization of Asn130-to-Ala mutant of dengue type 1 virus NS1 protein Virus Genes 36 323 329 18288598
174. P Avirutnan N Punyadee S Noisakran C Komoltri S Thiemmeca K Auethavornanan A Jairungsri R Kanlaya N Tangthawornchaikul C Puttikhunt SN Pattanakitsakul PT Yenchitsomanus J Mongkolsapaya W Kasinrerk N Sittisombut M Husmann M Blettner S Vasanawathana S Bhakdi P Malasit 2006 Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement J Infect Dis 193 1078 1088 16544248
175. R Anderson S Wang C Osiowy AC Issekutz 1997 Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes J Virol 71 4226 4232 9151809
176. GJ Chang AR Hunt DA Holmes T Springfield TS Chiueh JT Roehrig DJ Gubler 2003 Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus Virology 306 170 180 12620809
177. AK Falconar 1999 Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins Arch Virol 144 2313 2330 10664386
178. RT He BL Innis A Nisalak W Usawattanakul S Wang S Kalayanarooj R Anderson 1995 Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2 J Med Virol 45 451 461 7666046
179. EA Henchal JM McCown DS Burke MC Seguin WE Brandt 1985 Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies Am J Trop Med Hyg 34 162 169 2578750
180. JM Murray JG Aaskov PJ Wright 1993 Processing of the dengue virus type 2 proteins prM and C-prM J Gen Virol 74 Pt 2 175 182 8429301
181. MJ Pryor L Azzola PJ Wright AD Davidson 2004 Histidine 39 in the dengue virus type 2M protein has an important role in virus assembly J Gen Virol 85 3627 3636 15557235
182. DE Purdy GJ Chang 2005 Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein Virology 333 239 250 15721358
183. JT Roehrig RA Bolin RG Kelly 1998 Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica Virology 246 317 328 9657950
184. S Wang R He R Anderson 1999 PrM- and cell-binding domains of the dengue virus E protein J Virol 73 2547 2551 9971841
185. M Bray CJ Lai 1991 Dengue virus premembrane and membrane proteins elicit a protective immune response Virology 185 505 508 1926792
186. KJ Huang YS lin JH Huang HS Liu TM Yeh CC Liu HY Lei 2008 Anti-prM antibody as an autoantibody in Dengue virus infection Am J Infect Dis 4 59 67
187. SY Se-Thoe MM Ng AE Ling 1999 Retrospective study of Western blot profiles in immune sera of natural dengue virus infections J Med Virol 57 322 330 10022806
188. J Junjhon M Lausumpao S Supasa S Noisakran A Songjaeng P Saraithong K Chaichoun U Utaipat P Keelapang A Kanjanahaluethai C Puttikhunt W Kasinrerk P Malasit N Sittisombut 2008 Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction J Virol 82 10776 10791 18715923
189. P Keelapang R Sriburi S Supasa N Panyadee A Songjaeng A Jairungsri C Puttikhunt W Kasinrerk P Malasit N Sittisombut 2004 Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses J Virol 78 2367 2381 14963133
190. S Elshuber SL Allison FX Heinz CW Mandl 2003 Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus J Gen Virol 84 183 191 12533715
191. MV Cherrier B Kaufmann GE Nybakken SM Lok JT Warren BR Chen CA Nelson VA Kostyuchenko HA Holdaway PR Chipman RJ Kuhn MS Diamond MG Rossmann DH Fremont 2009 Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody EMBO J 28 3269 3276 19713934
192. SB Halstead TG Streit JG Lafontant R Putvatana K Russell W Sun N Kanesa-Thasan CG Hayes DM Watts 2001 Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission Am J Trop Med Hyg 65 180 183 11561700
193. Kouri G, Guzman MG, Valdes L, Carbonel I, del RD, Vazquez S, Laferte J, Delgado J, Cabrera MV (1998) Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis 4:89-92
194. GP Kouri MG Guzman JR Bravo C Triana 1989 Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981 Bull World Health Organ 67 375 380 2805215
195. P Chiewsilp RM Scott N Bhamarapravati 1981 Histocompatibility antigens and dengue hemorrhagic fever Am J Trop Med Hyg 30 1100 1105 7283007
196. C LaFleur J Granados G Vargas-Alarcon J Ruiz-Morales C Villarreal-Garza L Higuera G Hernandez-Pacheco T Cutino-Moguel H Rangel R Figueroa M Acosta E Lazcano C Ramos 2002 HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever Hum Immunol 63 1039 1044 12392857
197. H Loke DB Bethell CX Phuong M Dung J Schneider NJ White NP Day J Farrar AV Hill 2001 Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 184 1369 1373 11709777
198. HA Stephens R Klaythong M Sirikong DW Vaughn S Green S Kalayanarooj TP Endy DH Libraty A Nisalak BL Innis AL Rothman FA Ennis D Chandanayingyong 2002 HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais Tissue Antigens 60 309 318 12472660
199. I Zivna S Green DW Vaughn S Kalayanarooj HA Stephens D Chandanayingyong A Nisalak FA Ennis AL Rothman 2002 T cell responses to an HLA-B-07-restricted epitope on the dengue NS3 protein correlate with disease severity J Immunol 168 5959 5965 12023403
200. JR Polizel D Bueno JE Visentainer AM Sell SD Borelli LT Tsuneto MM Dalalio MT Coimbra RA Moliterno 2004 Association of human leukocyte antigen DQ1 and dengue fever in a white Southern Brazilian population Mem Inst Oswaldo Cruz 99 559 562 15558162
201. H Loke D Bethell CX Phuong N Day N White J Farrar A Hill 2002 Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes Am J Trop Med Hyg 67 102 106 12363051
202. MT Fernandez-Mestre K Gendzekhadze P Rivas-Vetencourt Z Layrisse 2004 TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients Tissue Antigens 64 469 472 15361124
203. RF Chen L Wang JT Cheng H Chuang JC Chang JW Liu IC Lin KD Yang 2009 Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak Clin Immunol 131 404 409 19269255
204. A Sakuntabhai C Turbpaiboon I Casademont A Chuansumrit T Lowhnoo A Kajaste-Rudnitski SM Kalayanarooj K Tangnararatchakit N Tangthawornchaikul S Vasanawathana W Chaiyaratana PT Yenchitsomanus P Suriyaphol P Avirutnan K Chokephaibulkit F Matsuda S Yoksan Y Jacob GM Lathrop P Malasit P Despres C Julier 2005 A variant in the CD209 promoter is associated with severity of dengue disease Nat Genet 37 507 513 15838506
205. YC Chao CS Huang CN Lee SY Chang CC King CL Kao 2008 Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency PLoS One 3 e1557 18270558
206. JR Bravo MG Guzman GP Kouri 1987 Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) Trans R Soc Trop Med Hyg 81 816 820 3450004
207. MG Guzman G Kouri 2002 Dengue: an update Lancet Infect Dis 2 33 42 11892494
208. MS Lee KP Hwang TC Chen PL Lu TP Chen 2006 Clinical characteristics of dengue, dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic J Microbiol Immunol Infect 39 121 129 16604244
209. A Ong M Sandar MI Chen LY Sin 2007 Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore Int J Infect Dis 11 263 267 16899384